期刊文献

Ticagrelor Versus Clopidogrel in Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention for Acute Coronary Syndrome in Chronic Kidney Disease 收藏

在慢性肾脏病急性冠状动脉综合征的经皮冠状动脉干预后，双重抗血小板治疗中的ticagrelor与氯吡格雷在双重抗血小板疗法中
原文求助 发布源
作者
Min Choon Tan (https://orcid.org/0000-0002-7682-8934) [1];Aravinthan Vignarajah [2];Tanusha Winson (https://orcid.org/0009-0003-1776-6205) [3];Yong Hao Yeo [4];Qi Xuan Ang [5];Ramzi Ibrahim [6];Justin Z. Lee [7];
发布日期
2025-6
页码
1-2
DOI
10.1016/j.amjcard.2025.02.016
来源信息
The American Journal of Cardiology ISSN：0002-9149, 2025年, 244卷, 1-2页
摘要
摘要译文
Min Choon Tan (https://orcid.org/0000-0002-7682-8934) [1];Aravinthan Vignarajah [2];Tanusha Winson (https://orcid.org/0009-0003-1776-6205) [3];Yong Hao Yeo [4];Qi Xuan Ang [5];Ramzi Ibrahim [6];Justin Z. Lee [7];. Ticagrelor Versus Clopidogrel in Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention for Acute Coronary Syndrome in Chronic Kidney Disease[J]. The American Journal of Cardiology, 2025,244: 1-2